The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Strategies to overcome resistance to enfortumab vedotin and pembrolizumab for patients with urothelial carcinoma: harnessing present knowledge for future advances”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2026 |
Sebastian C. Schmid, Matthias Jahnen, Kilian Schiller, Andreas Sauter, Anna K. Seitz, Florestan Koll, Franziska Wieck, Philipp Korn, Philipp Maisch, Kristina Schwamborn, Michael Flentje, Thomas Wiegel, Stephanie E. Combs, Friedemann Zengerling, Christian Bolenz, Hubert Kübler, Claus Rödel, Jürgen E. Gschwend, Margitta Retz, Jonas Lewerich. Radiation Therapy Combined with Immunotherapy Before Radical Cystectomy in Locally Advanced Bladder Cancer: A Prospective, Single-arm, Multicenter, Phase 2 Trial (RACE-IT), European Urology Oncology. 2026; https://doi.org/10.1016/j.euo.2026.02.019 |
|
2 |
2025 |
Namrata Ganguli, Sarbartha Mukherjee, Dibyendu Samanta. Membrane glycoprotein nectin-4 in tumor associated pathways and anti-cancer therapeutics, International Journal of Biological Macromolecules. 2025; 330: 148023148023. https://doi.org/10.1016/j.ijbiomac.2025.148023 |
|
3 |
2025 |
Takatoshi Somoto, Takanobu Utsumi, Rino Ikeda, Naoki Ishitsuka, Takahide Noro, Yuta Suzuki, Shota Iijima, Yuka Sugizaki, Ryo Oka, Takumi Endo, Naoto Kamiya, Hiroyoshi Suzuki. Navigating Therapeutic Landscapes in Urothelial Cancer: From Chemotherapy to Precision Immuno-Oncology, Cancers. 2025; 17: 3367. https://doi.org/10.3390/cancers17203367 |
|
4 |
2026 |
Jing Huang, Ademola Ojo, Bobby Liaw. Predictors of Response and Mechanisms of Resistance to Antibody Drug Conjugates in Urothelial Carcinoma, Current Oncology. 2026; 33: 103. https://doi.org/10.3390/curroncol33020103 |